K Phos Tablet, Soluble
NDC Package 0486-1111-05
Package Information
K Phos (potassium phosphate, monobasic) tablets is a medication contraindicated in patients with infected phosphate stones; in patients with severely impaired renal function (less than 30% of normal) and in the presence of hyperphosphatemia and hyperkalemia. This formulation utilizes a tablet, soluble delivery system. Marketed by Beach Products, Inc., this product is identified by NDC 0486-1111.
Identification & Billing
- RxCUI: 1101775 - monobasic potassium phosphate 0.0408 MEQ/ML Oral Solution
- RxCUI: 1101775 - Monobasic K+ phosphate 0.0408 MEQ/ML Oral Solution
- RxCUI: 1101775 - Monobasic Pot phosphate 0.0408 MEQ/ML Oral Solution
- RxCUI: 1101778 - K-Phos 500 MG Tablet for Oral Solution
- RxCUI: 1101778 - monobasic potassium phosphate 0.0408 MEQ/ML Oral Solution [K-Phos]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0486 - Beach Products, Inc.
- 0486-1111 - K Phos
- 0486-1111-05 - 500 TABLET, SOLUBLE in 1 BOTTLE
- 0486-1111 - K Phos
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0486-1111). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0486-1111-05 identifies a specific commercial package of 500 tablet, soluble in 1 bottle of K Phos Original, a human prescription drug labeled by Beach Products, Inc.. This tablet, soluble is formulated for oral use and contains potassium phosphate, monobasic as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Beach Products, Inc. on March 29, 1977. The current certification is valid through December 31, 2026.
How is this Beach Products, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00486111105. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 500 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.